| Title : Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease - Lakkappa_2018_Neurotoxicol_70_135 |
| Author(s) : Lakkappa N , Krishnamurthy PT , M DP , Hammock BD , Hwang SH |
| Ref : Neurotoxicology , 70 :135 , 2018 |
| Abstract : |
| PubMedSearch : Lakkappa_2018_Neurotoxicol_70_135 |
| PubMedID: 30472438 |
| Title : Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS\/MS method development - Lakkappa_2018_J.Pharm.Biomed.Anal_149_457 |
| Author(s) : Lakkappa N , Krishnamurthy PT , Yamjala K , Hwang SH , Hammock BD , Babu B |
| Ref : J Pharm Biomed Anal , 149 :457 , 2018 |
| Abstract : |
| PubMedSearch : Lakkappa_2018_J.Pharm.Biomed.Anal_149_457 |
| PubMedID: 29169114 |
| Title : Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS\/MS method development - Lakkappa_2018_J.Pharm.Biomed.Anal_149_457 |
| Author(s) : Lakkappa N , Krishnamurthy PT , Yamjala K , Hwang SH , Hammock BD , Babu B |
| Ref : J Pharm Biomed Anal , 149 :457 , 2018 |
| Abstract : |
| PubMedSearch : Lakkappa_2018_J.Pharm.Biomed.Anal_149_457 |
| PubMedID: 29169114 |
| Title : Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease - Lakkappa_2018_Neurotoxicol_70_135 |
| Author(s) : Lakkappa N , Krishnamurthy PT , M DP , Hammock BD , Hwang SH |
| Ref : Neurotoxicology , 70 :135 , 2018 |
| Abstract : |
| PubMedSearch : Lakkappa_2018_Neurotoxicol_70_135 |
| PubMedID: 30472438 |
| Title : Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease - Lakkappa_2018_Neurotoxicol_70_135 |
| Author(s) : Lakkappa N , Krishnamurthy PT , M DP , Hammock BD , Hwang SH |
| Ref : Neurotoxicology , 70 :135 , 2018 |
| Abstract : |
| PubMedSearch : Lakkappa_2018_Neurotoxicol_70_135 |
| PubMedID: 30472438 |
| Title : Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS\/MS method development - Lakkappa_2018_J.Pharm.Biomed.Anal_149_457 |
| Author(s) : Lakkappa N , Krishnamurthy PT , Yamjala K , Hwang SH , Hammock BD , Babu B |
| Ref : J Pharm Biomed Anal , 149 :457 , 2018 |
| Abstract : |
| PubMedSearch : Lakkappa_2018_J.Pharm.Biomed.Anal_149_457 |
| PubMedID: 29169114 |
| Title : Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease - Chintamaneni_2017_Med.Hypotheses_101_17 |
| Author(s) : Chintamaneni PK , Krishnamurthy PT , Rao PV , Pindiprolu SS |
| Ref : Med Hypotheses , 101 :17 , 2017 |
| Abstract : |
| PubMedSearch : Chintamaneni_2017_Med.Hypotheses_101_17 |
| PubMedID: 28351483 |
| Title : Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease - Chintamaneni_2017_Med.Hypotheses_101_17 |
| Author(s) : Chintamaneni PK , Krishnamurthy PT , Rao PV , Pindiprolu SS |
| Ref : Med Hypotheses , 101 :17 , 2017 |
| Abstract : |
| PubMedSearch : Chintamaneni_2017_Med.Hypotheses_101_17 |
| PubMedID: 28351483 |
| Title : Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease - Chintamaneni_2017_Med.Hypotheses_101_17 |
| Author(s) : Chintamaneni PK , Krishnamurthy PT , Rao PV , Pindiprolu SS |
| Ref : Med Hypotheses , 101 :17 , 2017 |
| Abstract : |
| PubMedSearch : Chintamaneni_2017_Med.Hypotheses_101_17 |
| PubMedID: 28351483 |